AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201503-01-2023
03-01-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Closure of Trading Window
Intimation of closure of Trading Window29-12-2022
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Closure of Trading Window
Intimation of closure of Trading Window29-12-2022
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to abovementioned regulation, intimation is hereby given that the Company has received a request from the below-mentioned shareholder for issuance of Duplicate Share Certificate consequent to loss of original Share Certificate. Also request you to note that the Company/RTA is processing the request for issuing the said duplicate share certificate and will issue the same within the stipulated time period.15-12-2022
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Pursuant to the Regulation 23(9) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the disclosure of Related Party Transactions on a Standalone basis, for the half year ended on September 30, 2022.18-11-2022
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30 read with Para A of Part A of schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby enclose the Investor Presentation for the quarter and half year ended 30th September 202205-11-2022
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Un-Audited Financial Results For Period Ended September 30, 2022
Approved the Un-audited Financial Results for the quarter and half year ended September 30, 2022. The same along with the Limited Review Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company is enclosed04-11-2022
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Board Meeting Outcome for Outcome Of The Board Meeting
In terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), we wish to inform that the Board of Directors of the Company at its meeting held today (November 04, 2022) had inter-alia: (i) Approved the Un-audited Financial Results for the quarter and half year ended September 30, 2022. The same along with the Limited Review Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company is enclosed. (ii) Declared First Interim Dividend of Re.1/- per share for the financial year 2022-23 on the Equity Shares of the Company.04-11-2022
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Intimation Under Regulation 30 Of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015 (SEBI LODR) Regarding New Product Launch
Pursuant to regulation 30 of SEBI LODR, we hereby attach an announcement regarding the new product launch. We request to take the above on record and disseminate the same02-11-2022
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - First Interim Dividend 2022-23
Pursuant to regulation 42 of SEBI LODR, we wish to inform that the Company has fixed 15th November 2022 as record date for payment of First Interim Dividend for the financial year 2022-23, if approved, to members whose name appear in the register of Members and as the beneficial owners as per the details received from National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL) as on the record date.27-10-2022